Literature DB >> 24795259

Papillary thyroid cancer: strategies for optimal individualized surgical management.

Clive S Grant1.   

Abstract

OBJECTIVE: The goal of this article was to describe the optimal individualized surgical management of patients with papillary thyroid cancer (PTC).
METHODS: This summary reviews the relevant literature that takes into account description of the context of disease incidence, current practice guidelines, controversies in the management of thyroid resection and management of central neck lymph nodes, alternative methods of treatment, and evidence from the author's institution to support the final recommendations.
RESULTS: Combining the rationale for treatment decisions from the Mayo Clinic's surgical management of PTC, plus recently published large institutional series and a meta-analysis of patient outcomes, the recommendations for PTC >1 cm include the following: (1) preoperative ultrasound to identify and map the location of lateral jugular lymph node metastasis; (2) bilateral total or near-total thyroidectomy; (3) routine central neck (compartment VI) lymph node dissection; and (4) inclusion of lateral neck lymph node dissection when indicated. Alterations are advised depending on either the level of expertise or anatomic findings at the time of performing the thyroidectomy and lymph node dissection.
CONCLUSIONS: Because all of the data presented from the Mayo Clinic and the literature fall short of Level 1 evidence, these recommendations should not be considered dogmatic nor should they exclude reasonable alternatives that are also presented.
Copyright © 2014 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Keywords:  central neck dissection; lymph node metastasis; papillary thyroid cancer; thyroidectomy

Mesh:

Year:  2014        PMID: 24795259     DOI: 10.1016/j.clinthera.2014.03.016

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  10 in total

1.  Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.

Authors:  Yang-Jing Chen; Rui-Min Zhao; Qian Zhao; Bai-Ya Li; Qing-Yong Ma; Xiao Li; Xia Chen
Journal:  Tumour Biol       Date:  2016-01-07

2.  Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.

Authors:  W Liang; F Sun
Journal:  J Endocrinol Invest       Date:  2018-03-08       Impact factor: 4.256

3.  Preoperative ultrasound evaluation of laterocervical lymph nodes: timing and experience modify the treatment of patients with differentiated thyroid cancer.

Authors:  Marica Grasso; Alessandro Puzziello; Maurizio De Palma
Journal:  Updates Surg       Date:  2019-01-02

4.  Immediate Surgery Might Be a Better Option for Subcapsular Thyroid Microcarcinomas.

Authors:  Jun Jiang; Hui Lu
Journal:  Int J Endocrinol       Date:  2019-04-03       Impact factor: 3.257

5.  Identification of a Six Gene Prognosis Signature for Papillary Thyroid Cancer Using Multi-Omics Methods and Bioinformatics Analysis.

Authors:  He Ren; Xin Liu; Fuxin Li; Xianghui He; Na Zhao
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

6.  Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.

Authors:  Jing Ma; Wei Han; Kai Lu
Journal:  Front Oncol       Date:  2021-08-20       Impact factor: 6.244

7.  Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion.

Authors:  Xiaolin Yang; Yukun Li; Geling Liu; Weina Zha; Ying Liu
Journal:  Oncol Lett       Date:  2022-03-15       Impact factor: 2.967

8.  Identification of a Four-Gene Signature for Determining the Prognosis of Papillary Thyroid Carcinoma by Integrated Bioinformatics Analysis.

Authors:  Yuting Luo; Rong Chen; Zhikun Ning; Nantao Fu; Minghao Xie
Journal:  Int J Gen Med       Date:  2022-02-04

9.  Identification of prognostic biomarkers for papillary thyroid carcinoma by a weighted gene co-expression network analysis.

Authors:  Kexin Meng; Xiaotian Hu; Guowan Zheng; Chenhong Qian; Ying Xin; Haiwei Guo; Ru He; Minghua Ge; Jiajie Xu
Journal:  Cancer Med       Date:  2022-02-12       Impact factor: 4.711

10.  Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT.

Authors:  Ari Chong; Jung-Min Ha; Yeon-Hee Han; Eunjung Kong; Yunjung Choi; Ki Hwan Hong; Jun-Hee Park; Sung Hoon Kim; Jung Mi Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-06-18       Impact factor: 3.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.